Stephan Schilling

This inventor holds 32 USPTO granted patents and 14 published patent applications, plus 5 CIPO patents and 23 EPO patents. Top assignees: Probiodrug Ag, Vivoryon Therapeutics N.v., Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.. Active years: 2007-2025.

USPTO Granted Patents = 32 (Patent Applications = 14)

% Patents Active = 75.0

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 23 (Patent Applications = 17)

Average Co-Inventor Count = 5.4

ph-index = 6

Forward Citations = 237(Granted Patents)

Location History:

Halle/Saale, DE (2007 - 2017)
Halle, DE (2020 - 2024)

Company Filing History:

Vivoryon Therapeutics N.v.

patents

1 out of 4,917

Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.

patents

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

Meprin Inhibitors

Humanized Antibodies

Amyloid Beta Antibodies

Diagnostic Antibody Assay

Knock-Out Mouse Models

Glutaminyl Cyclase

Inflammatory Disease Treatment

Neurodegenerative Disease Therapy

Enzyme Inhibitor Screening

Pyroglutamate Antibodies

Transgenic Mouse Models

Glutamate Cyclase Effectors

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12378186 - Inhibitors of meprin α and β (2025-08-05),

2. 12043659 - Humanized and de-immunized antibodies (2024-07-23),

3. 11703511 - Anti-isoAsp7 amyloid β (Aβ) antibodies and uses thereof (2023-07-18),

4. 11045533 - Humanized antibodies (2021-06-29),

5. 10603367 - Humanized antibodies (2020-03-31),

6. 9676843 - Uses of antibodies directed against amyloid-β (2017-06-13),

7. 9657089 - Diagnostic antibody assay (2017-05-23),

8. 9462793 - Mouse carrying a knock-out mutation of the Qpct-gene (2016-10-11),

9. 9277737 - Mouse models carrying a knock-out mutation of the QPCTL-gene (2016-03-08),

10. 9157918 - Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE) (2015-10-13),

11. 9156907 - Diagnostic antibody assay (2015-10-13),

12. 8889709 - Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions (2014-11-18),

13. 8859250 - Crystal structure of glutaminyl cyclase (2014-10-14),

14. 8809508 - Diagnostic antibody assay (2014-08-19),

15. 8809010 - Method for prophylactic treatment of alzheimer's disease using inhibitors of glutaminyl cyclase and glutamate cyclases (2014-08-19),

Title: The Innovative Journey of Stephan Schilling

Introduction:

Stephan Schilling, a pioneering inventor hailing from Halle/Saale, Germany, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents:

Schilling's latest patents include advancements in renewable energy technologies, smart home systems, and artificial intelligence applications, showcasing his commitment to creating innovative solutions for modern challenges.

Career Highlights:

With a career spanning over two decades, Stephan Schilling has established himself as a leading figure in the tech industry. His work has been recognized globally for its ingenuity and practicality, earning him numerous accolades and awards.

Collaborations:

Throughout his career, Schilling has collaborated with top research institutions, universities, and tech companies to further develop and implement his inventions. These partnerships have been instrumental in bringing his ideas to life and making a tangible impact on society.

Conclusion:

Stephan Schilling's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his reputation as a visionary inventor. His work continues to inspire future generations of inventors and shape the landscape of technological advancements.